Evidence map›Paper›PMID 35464878›Full record

ArticleTherapeutic advances in endocrinology and metabolism2022

In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity.

Marwa Al-Badri, Cara L Kilroy, Jacqueline Ifat Shahar, Shaheen Tomah, Hannah Gardner, Mallory Sin, Jennie Votta, Aliza Phillips-Stoll, Aaron Price, Joan Beaton and 4 more

Abstract read
In one paragraph

Article in Therapeutic advances in endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Virtual Education Protocol for Sustainable Lifestyle Modifications.International journal of preventive medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marwa Al-BadriJoslin Diabetes Center, Affiliated with Harvard Medical School, One Joslin Place, Room 316, Boston, MA 02215, USA.ORCID https://orcid.org/0000-0002-4998-9708
Cara L KilroyJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Jacqueline Ifat ShaharJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Shaheen TomahJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Hannah GardnerJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Mallory SinJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Jennie VottaJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Aliza Phillips-StollJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Aaron PriceJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Joan BeatonJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Chandra DavisJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Jo-Anne RizzottoJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Shilton DhaverJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.
Osama HamdyJoslin Diabetes Center, Affiliated with Harvard Medical School, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intensive lifestyle intervention (ILI) is essential for diabetes management. The Weight Achievement and Intensive Treatment (Why WAIT) program is a 12-week multidisciplinary weight management program that has been implemented in real-world clinical practice since 2005 and has shown long-term maintenance of weight reduction for 5 and 10 years. During the COVID-19 pandemic, the program went virtual using telemedicine and mobile health applications. Aims: This retrospective pilot study aims to evaluate the effectiveness of a virtual model of an already established and successful in-person program for diabetes and weight management since 2005. Methods: We evaluated 38 patients with diabetes and obesity enrolled in the Why WAIT program between February 2019 and December 2020. Sixteen participants were enrolled in virtual program (VP) and were compared with 22 participants who completed the latest two physical programs (PPs) before COVID-19. We evaluated changes in body weight, A1C, blood pressure (BP), and lipid profile after 12 weeks of ILI. Results: Body weight decreased by -7.4 ± 3.6 kg from baseline in VP compared with -6.8 ± 3.5 kg in PP ( Conclusion: Virtual multidisciplinary ILI is as effective as the in-person intervention program in improving body weight, A1C, BP, and lipid profile, and in reducing the number of anti-hyperglycemic medications. Results from our study suggest that scaling the Why WAIT program in a virtual format to a larger population of patients with diabetes and obesity is feasible and is potentially as successful as the in-person program.

Indexed as

COVID-19diabetesdigital healthhealthcareintensive lifestylem-Healthtechnologytelemedicinevirtual

Identifiers

PMID35464878
PMCPMC9019312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.